Search





Search





Markets
/
Stocks
/
nrix
/

Nurix Therapeutics Inc

NRIX

Add to Watchlist

23.210USD

-0.370-1.57%

Close 07-31 16:00（ET）Quotes delayed by 15 min

2.41BMarket Cap

LossP/E TTM

Nurix Therapeutics Inc

23.210

-0.370-1.57%

TradingKey Stock Score Overall Financial Health Valuation Dimensions Earnings Forecast Price Momentum Institutional Confidence Risk Assessment

Overview

Financials

Discussions

Analysis

Company

TradingKey Stock Score Overall Financial Health Valuation Dimensions Earnings Forecast Price Momentum Institutional Confidence Risk Assessment

Institutional Confidence

Currency: USD Updated: 2026-07-31

Previous score

10.00

Change

The current institutional shareholding score of Nurix Therapeutics Inc is 10.00, ranking 1 out of 385 in the Biotechnology & Medical Research industry. The latest institutional shareholding proportion is 118.09%, representing a quarter-over-quarter increase of 38.35%. The largest institutional shareholder is Bill Nygren | OAKMX, holding a total of 1.53M shares, representing 1.66% of shares outstanding, with 15.31% decrease in holdings.

Institutional Shareholding

Shareholder Activity

Name

Shares Held

Chg %

Redmile Group, LLC

8.09M

+120.04%

BlackRock Institutional Trust Company, N.A.

7.76M

+34.85%

Deep Track Capital LP

7.04M

+16.17%

General Atlantic LLC

4.90M

Vestal Point Capital, LP

4.69M

+34.96%

Morgan Stanley & Co. LLC

4.69M

+129.14%

Baker Bros. Advisors LP

4.66M

+20.00%

Fidelity Management & Research Company LLC

4.00M

-47.24%

State Street Investment Management (US)

3.56M

+24.35%